PLACENTAL PROTEIN 5 (PP5) IN COMPLICATED PREGNANCIES
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1981.tb01022.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b)
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 88, Issue 5, pages 492–499, May 1981
Additional Information
How to Cite
Nisbet, A. D., Bremner, R. D., Jandial, V., Sutherland, H. W., Horne, C. H. W. and Bohn, H. (1981), PLACENTAL PROTEIN 5 (PP5) IN COMPLICATED PREGNANCIES. BJOG: An International Journal of Obstetrics & Gynaecology, 88: 492–499. doi: 10.1111/j.1471-0528.1981.tb01022.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Received September 8, 1980/Accepted December 12, 1980
- Abstract
- References
- Cited By
Summary
Maternal serum PP5 concentrations were assayed in pregnancies complicated by intrauterine growth retardation, pre-eclampsia, diabetes mellitus, placental abruption and twins. Elevated PP5 levels were noted in twin pregnancies and to a lesser extent in diabetes and pre-eclampsia. Measurement of PP5 was of no value in the detection of fetal growth retardation. The great majority of PP5 levels above the normal range were associated with a placental abnormality.

1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)